Neos Therapeutics, Inc. 4
4 · Neos Therapeutics, Inc. · Filed Apr 1, 2016
Insider Transaction Report
Form 4
Engelking Dorothy
VP, Regulatory Affairs
Transactions
- Award
Stock Option (Right to Buy)
2016-04-01+15,000→ 15,000 totalExercise: $10.74Exp: 2026-04-01→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]This stock option vests in four equal, annual installments, beginning on April 1, 2017.